Barclays lowered the firm’s price target on Marex Group (MRX) to $50 from $52 and keeps an Overweight rating on the shares following the Q2 report. The company reported an earnings beat and its sales momentum continued into July, the analyst tells investors in a research note. The firm believes Marex also provided a strong rebuttal to a recent short report, answering many key questions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRX: